Vetter has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions — to small, midsize and large pharma and biotech companies.
End-to-end support for Pharma and Biotech companies
The manufacture of biologic drug products is quite complex and requires specialized expertise. Early and careful planning for the future can significantly contribute to the success of a development project. In addition, startups that pursue projects from the very start with the end goals (packaged final products) in mind often attract the financial assistance of large companies, relationships that can lead to out-licensing deals or even acquisitions. For both small and large drug developers, using different service providers for different phases of the development and commercialization cycle can increase both cost and risk due to the need for technology transfer activities. In addition, with an end-to-end partner, knowledge gained during early development work is retained and can be applied during late-stage process development.
Vetter has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions — to small, midsize and large pharma and biotech companies. We specialize in the aseptic manufacturing of prefilled syringes, cartridges and vials and have experience with monoclonal antibodies, peptides, interferons, vaccines and other complex compounds. Our state-of-the-art technologies and innovative processes are able to improve product quality and maximize API yields.
Vetter Development Service partners with customers from preclinical development through Phase III, planning for commercial production from a product’s earliest stages. Services include formulation support, process development, clinical trial manufacturing and analytical and regulatory support. We develop processes that mirror those at our commercial production facilities, enabling later product transfers to our large-scale manufacturing.
Vetter Commercial Manufacturing provides Phase III manufacturing through to a global market supply. At this level, Vetter offers a full range of services to deliver quality across the supply chain, including fill & finish, analytical services, regulatory support and product lifecycle management activities. These efforts are backed by measures taken both downstream and upstream to strengthen security of supply, including regular quality reviews of suppliers and cross-linked IT systems to monitor manufacturing processes.
Vetter Packaging Solutions matches customer products with appropriate drug-delivery systems (primary packaging); and provides secondary packaging, such as cartoning or blister packing, and other packaging services, including pen system assembly, printing and labeling, and serialization. Our capabilities include customized packaging development, specialized technologies, platform technologies, and packaging and logistics services.
Clinical manufacturing is performed at a dedicated facility in Chicago, USA and in Ravensburg, Germany, where Vetter also operates three commercial facilities, a secondary packaging facility and a center for visual inspection and logistics.
Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. Currently employing 4,500 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability.